Quadrant Capital Group’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-319
| Closed | -$1.29K | – | 2708 |
|
|
2024
Q1 | $1.29K | Buy |
+319
| New | +$1.29K | ﹤0.01% | 2559 |
|
|
2023
Q2 | – | Sell |
-58
| Closed | -$195 | – | 2693 |
|
|
2023
Q1 | $195 | Buy |
+58
| New | +$195 | ﹤0.01% | 2676 |
|
|
2022
Q4 | – | Sell |
-87
| Closed | – | – | 2742 |
|
|
2022
Q3 | $0 | Sell |
87
-43
| -33% | – | ﹤0.01% | 2636 |
|
|
2022
Q2 | $1K | Buy |
+130
| New | +$1K | ﹤0.01% | 2320 |
|
|
2022
Q1 | – | Sell |
-46
| Closed | – | – | 2497 |
|
|
2021
Q4 | $0 | Buy |
46
+22
| +92% | – | ﹤0.01% | 2506 |
|
|
2021
Q3 | $1K | Buy |
+24
| New | +$1K | ﹤0.01% | 2245 |
|